Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.24B |
| 2 |
Microsoft
MSFT
|
+$433M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$419M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$332M |
| 5 |
RTX Corp
RTX
|
+$322M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AABA
Altaba Inc
AABA
|
+$267M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$181M |
| 3 |
BCR
CR Bard Inc.
BCR
|
+$134M |
| 4 |
IQVIA
IQV
|
+$134M |
| 5 |
LVLT
Level 3 Communications Inc
LVLT
|
+$121M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.07% |
| 2 | Financials | 5.97% |
| 3 | Healthcare | 5.8% |
| 4 | Consumer Discretionary | 5.2% |
| 5 | Communication Services | 4.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4301
CALL
Boston Scientific
BSX
$71.5B
| $290K | ﹤0.01% |
11,700
-9,900
| -46% | -$273K |
|
|
INVX
4302
Innovex International
INVX
$1.97B
| $290K | ﹤0.01% |
6,064
+4,290
| +242% | +$192K |
|
4303
PUT
ProShares Ultra Energy
DIG
$76.9M
| $289K | ﹤0.01% |
5,840
-4,080
| -41% | -$182K |
|
4304
Direxion Daily Real Estate Bear 3X ETF
DRV
$25.7M
| $289K | ﹤0.01% |
552
| – | – |
|
4305
IAMGOLD
IAG
$10.6B
| $289K | ﹤0.01% |
49,616
+20,260
| +69% | +$116K |
|
4306
CALL
Robert Half
RHI
$4.37B
| $289K | ﹤0.01% |
5,200
+4,900
| +1,633% | +$261K |
|
|
CNSL
4307
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $288K | ﹤0.01% |
23,748
+22,233
| +1,468% | +$349K |
|
|
GLOP
4308
DELISTED
GASLOG PARTNERS LP
GLOP
| $288K | ﹤0.01% |
11,650
+2,229
| +24% | +$51.7K |
|
|
NGHC
4309
DELISTED
National General Holdings Corp
NGHC
| $288K | ﹤0.01% |
14,679
+10,107
| +221% | +$207K |
|
4310
Bank of Hawaii
BOH
$3.13B
| $287K | ﹤0.01% |
3,343
-2,051
| -38% | -$171K |
|
4311
CALL
Popular Inc
BPOP
$11.1B
| $287K | ﹤0.01% |
8,100
+600
| +8% | +$20.7K |
|
4312
Lakeland Financial Corp
LKFN
$1.53B
| $287K | ﹤0.01% |
5,926
+2,422
| +69% | +$119K |
|
4313
Northwest Bancshares
NWBI
$2.28B
| $287K | ﹤0.01% |
17,147
+14,708
| +603% | +$247K |
|
4314
CALL
AGCO
AGCO
$7.2B
| $286K | ﹤0.01% |
4,000
+2,600
| +186% | +$186K |
|
4315
Iovance Biotherapeutics
IOVA
$2.83B
| $286K | ﹤0.01% |
35,799
+32,563
| +1,006% | +$261K |
|
|
KG
4316
Kestrel Group
KG
$69M
| $286K | ﹤0.01% |
2,167
+407
| +23% | +$60.9K |
|
|
GOV
4317
DELISTED
Government Properties Income Trust
GOV
| $286K | ﹤0.01% |
15,390
-39,884
| -72% | -$744K |
|
4318
AnaptysBio
ANAB
$1.68B
| $285K | ﹤0.01% |
2,830
+2,552
| +918% | +$188K |
|
|
BLUE
4319
PUT
DELISTED
bluebird bio
BLUE
| $285K | ﹤0.01% |
124
-30
| -19% | -$60.9K |
|
4320
Sonoco
SON
$5.74B
| $285K | ﹤0.01% |
5,361
-2,523
| -32% | -$132K |
|
4321
CALL
Wabtec
WAB
$49.3B
| $285K | ﹤0.01% |
3,500
+2,700
| +338% | +$206K |
|
|
EBIX
4322
CALL
DELISTED
Ebix Inc
EBIX
| $285K | ﹤0.01% |
3,600
-8,400
| -70% | -$611K |
|
|
WPX
4323
DELISTED
WPX Energy, Inc.
WPX
| $284K | ﹤0.01% |
20,211
-8,676
| -30% | -$105K |
|
|
SDRL
4324
DELISTED
Seadrill Limited Common Stock
SDRL
| $284K | ﹤0.01% |
4,589
+396
| +9% | +$31.6K |
|
4325
PUT
Jones Lang LaSalle
JLL
$16.7B
| $283K | ﹤0.01% |
1,900
-500
| -21% | -$70.7K |
|
Similar funds
Barclays's Q4 2017 Portfolio in Review
As of Q4 2017, Barclays held 7,416 positions worth $122B, up 26% from $97.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays deployed $19.9B of net new capital in Q4 2017, opening 435 new positions and adding to 3,853 existing holdings. Its largest new stake was iShares US Home Construction ETF: 198,606 shares worth $8.68M.
By sector, the portfolio is most concentrated in Technology at 7.1% of assets, up from 6.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Altaba Inc, an estimated $267M trimmed.
- Barclays's largest Q4 2017 buy was iShares US Home Construction ETF: 198,606 shares worth $8.68M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.24B increase.
- Barclays's biggest Q4 2017 reduction was Altaba Inc, cutting an estimated $267M.
- Barclays fully exited CR Bard Inc. in Q4 2017, selling an estimated $134M.
- Barclays's ten largest holdings make up 24% of its $122B portfolio in Q4 2017.
- Barclays opened 435 new positions and closed 356 in Q4 2017.
- Barclays's portfolio value rose 26% quarter-over-quarter to $122B.
Based on Barclays's 13F filing for Q4 2017, filed 14 Feb 2018.